// Weight Loss
Tirzepatide + NAD⁺
Dual incretin + mitochondrial energy. Pairs tirzepatide with NAD⁺ in a single vial.
- ✓Tirzepatide (dual incretin) + NAD⁺ in one sterile vial
- ✓Designed for patients seeking both weight-loss and energy support
- ✓Compounded under USP 797 sterile standards
- ✓Single weekly injection protocol
Starting from
Sign-in required. A licensed physician reviews every prescription before it ships.
Read the full protocol ↓// All formulations
1 formulation available
For orientation only — your physician confirms the final protocol on the pharmacy storefront.
| Option | Size | Price |
|---|---|---|
| Combination injectable | 5 mL vial | $303 |
Compounded by Greenstone Rx · Florida 503A pharmacy
Continue to Pharmacy →// The science
About Tirzepatide + NAD⁺
A dual-action compounded injectable pairing tirzepatide (dual GLP-1 + GIP agonist for appetite and glycemic control) with NAD⁺ (cellular energy and mitochondrial support). 100 mg tirzepatide and 1,000 mg NAD⁺ per vial.
// How it works
How it works
Tirzepatide activates both GLP-1 and GIP gut-hormone receptors — the dual mechanism that produces greater average weight loss than GLP-1 alone in head-to-head trials. The NAD⁺ component restores a coenzyme central to mitochondrial energy production, supporting daytime stamina that can dip during weight-loss titration.
// Who it's for
Who it's for
Patients pursuing significant weight loss who also want metabolic and energy support. Adults whose providers think the GIP component plus NAD⁺ would help when single-agent options have plateaued.
// What to expect
Your timeline
Appetite and weight-loss curve follows the standard tirzepatide protocol. Many patients report better daytime stamina than tirzepatide alone, attributed to the NAD⁺ component. Weekly injection protocol.
// Who should not take this
Who should not take this
Same as tirzepatide alone: medullary thyroid carcinoma history, MEN-2 syndrome, pregnancy, active pancreatitis, severe gallbladder disease. Discuss with provider if on cancer therapy.
// Typical starting dose
Typical starting dose
A typical starting protocol is one combination injection weekly, dosed to match a tirzepatide starter. Your physician will determine the right starting dose during the screening. Suggestions only — your physician reviews and approves the final protocol before any medication ships.
// Ready when you are
Start your prescription.
You'll complete a short health screening on the pharmacy storefront. A licensed physician reviews every order before any medication ships.
Continue to Pharmacy →Compounded by a 503A licensed pharmacy pursuant to a valid prescription. Not an FDA-approved drug. Not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Full disclaimer.